Opentrons
Also known as Opentrons Labworks
Makes open, programmable benchtop lab robots, the Flex and the smaller OT-2, that pipette liquids and move plates, with software meant to let AI models design, run and refine experiments on them; it says over 11,000 are deployed in more than 80 countries.
Money and evidence
No research by this company is on the record yet.
Rounds and research, on one timeline
- 2026-10-29Series ERound
$40M
For: scale its robotics, software and data infrastructure tools, invest in AI-driven experimental execution, extend its automation, and expand into new markets and geographies
Automated labModels and platformCommercial roll-out
The company's Business Wire release, read in BioSpace's copy. It names SoftBank Vision Fund and Khosla Ventures as existing investors without saying they joined this round, and gives no valuation or total raised.
Lead · AvegoBroadOak Capital Partners
On the deal: James Flexner (Managing Partner; spoke for the lead in the announcement, Avego)
- 2021-09-24Series CRound
$200M
For: new robotic tools, an expanded biofoundry, new diagnostic tests and additional diagnostic labs
Automated labWet labCommercial roll-out
Read in the note of the company's counsel, Orrick, dated 24 September 2021; the company's own Business Wire release of the day before could not be opened.
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
Its investors also backed
Other companies on this page whose rounds name the same investor.
- Khosla VenturesNoetik, Discovery Loop, Relation Therapeutics, Vinci